794 related articles for article (PubMed ID: 22737048)
1. Therapeutic siRNA: principles, challenges, and strategies.
Gavrilov K; Saltzman WM
Yale J Biol Med; 2012 Jun; 85(2):187-200. PubMed ID: 22737048
[TBL] [Abstract][Full Text] [Related]
2. RNAi therapeutics: principles, prospects and challenges.
Aagaard L; Rossi JJ
Adv Drug Deliv Rev; 2007 Mar; 59(2-3):75-86. PubMed ID: 17449137
[TBL] [Abstract][Full Text] [Related]
3. Functional nanostructures for effective delivery of small interfering RNA therapeutics.
Hong CA; Nam YS
Theranostics; 2014; 4(12):1211-32. PubMed ID: 25285170
[TBL] [Abstract][Full Text] [Related]
4. Targeted delivery systems of small interfering RNA by systemic administration.
Kawakami S; Hashida M
Drug Metab Pharmacokinet; 2007 Jun; 22(3):142-51. PubMed ID: 17603214
[TBL] [Abstract][Full Text] [Related]
5. Strategies for in vivo siRNA delivery in cancer.
Sanguino A; Lopez-Berestein G; Sood AK
Mini Rev Med Chem; 2008 Mar; 8(3):248-55. PubMed ID: 18336345
[TBL] [Abstract][Full Text] [Related]
6. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
[TBL] [Abstract][Full Text] [Related]
7. Molecular design and delivery of siRNA.
Inoue A; Sawata SY; Taira K
J Drug Target; 2006; 14(7):448-55. PubMed ID: 17062391
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.
Miele E; Spinelli GP; Miele E; Di Fabrizio E; Ferretti E; Tomao S; Gulino A
Int J Nanomedicine; 2012; 7():3637-57. PubMed ID: 22915840
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy.
Babu A; Muralidharan R; Amreddy N; Mehta M; Munshi A; Ramesh R
IEEE Trans Nanobioscience; 2016 Dec; 15(8):849-863. PubMed ID: 28092499
[TBL] [Abstract][Full Text] [Related]
10. Strategies for silencing human disease using RNA interference.
Kim DH; Rossi JJ
Nat Rev Genet; 2007 Mar; 8(3):173-84. PubMed ID: 17304245
[TBL] [Abstract][Full Text] [Related]
11. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics.
Gentile E; Oba T; Lin J; Shao R; Meng F; Cao X; Lin HY; Mourad M; Pataer A; Baladandayuthapani V; Cai D; Roth JA; Ji L
Oncotarget; 2017 Jul; 8(29):48222-48239. PubMed ID: 28637023
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in siRNA delivery.
Sarisozen C; Salzano G; Torchilin VP
Biomol Concepts; 2015 Dec; 6(5-6):321-41. PubMed ID: 26609865
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.
Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T
Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620
[TBL] [Abstract][Full Text] [Related]
14. Advances in siRNA delivery in cancer therapy.
Singh A; Trivedi P; Jain NK
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):274-283. PubMed ID: 28423924
[TBL] [Abstract][Full Text] [Related]
15. Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy.
Mainini F; Eccles MR
Molecules; 2020 Jun; 25(11):. PubMed ID: 32532030
[TBL] [Abstract][Full Text] [Related]
16. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
DeVincenzo JP
Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462
[TBL] [Abstract][Full Text] [Related]
17. In vivo delivery of RNAi with lipid-based nanoparticles.
Huang L; Liu Y
Annu Rev Biomed Eng; 2011 Aug; 13():507-30. PubMed ID: 21639780
[TBL] [Abstract][Full Text] [Related]
18. RNA interference-based therapy and its delivery systems.
Chen X; Mangala LS; Rodriguez-Aguayo C; Kong X; Lopez-Berestein G; Sood AK
Cancer Metastasis Rev; 2018 Mar; 37(1):107-124. PubMed ID: 29243000
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle-based delivery system for application of siRNA in vivo.
Wang Y; Li Z; Han Y; Liang LH; Ji A
Curr Drug Metab; 2010 Feb; 11(2):182-96. PubMed ID: 20359287
[TBL] [Abstract][Full Text] [Related]
20. Nonviral in vivo delivery of therapeutic small interfering RNAs.
Aigner A
Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]